Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$297K Buy
2,200
+284
+15% +$38K 0.01% 1044
2024
Q2
$260K Sell
1,916
-21
-1% -$2.86K 0.01% 1049
2024
Q1
$250K Sell
1,937
-355
-15% -$42.9K 0.01% 1074
2023
Q4
$262K Sell
2,292
-1,917
-46% -$191K 0.01% 997
2023
Q3
$383K Sell
4,209
-426
-9% -$43.9K 0.01% 761
2023
Q2
$522K Buy
+4,635
New +$490K 0.02% 650
2021
Q4
Sell
-2,052
Closed -$254K 1224
2021
Q3
$254K Sell
2,052
-104
-5% -$13.4K 0.01% 931
2021
Q2
$258K Sell
2,156
-239
-10% -$27.3K 0.01% 929
2021
Q1
$252K Sell
2,395
-1,182
-33% -$120K 0.01% 909
2020
Q4
$364K Buy
3,577
+566
+19% +$53.2K 0.01% 673
2020
Q3
$253K Buy
+3,011
New +$234K 0.01% 773

Other funds holding XYL

Raymond James Trust's XYL Position: Q3 2024 in Review

Raymond James Trust increased its Xylem (XYL) stake by 15% in Q3 2024, buying an estimated $38K and bringing the position to 2,200 shares worth $297K. The position accounts for 0.01% of the portfolio, ranked #1044.

Raymond James Trust first reported a position in XYL in Q3 2020 and has held it in 11 quarters since. The position peaked at $522K in Q2 2023. 1,016 funds tracked by Wall St. Rank hold XYL as of Q3 2024.

  • Raymond James Trust held 2,200 shares of Xylem worth $297K as of Q3 2024.
  • Raymond James Trust bought 284 Xylem shares in Q3 2024, an estimated $38K.
  • Xylem made up 0.01% of Raymond James Trust's portfolio in Q3 2024, its #1044 holding.
  • Raymond James Trust first reported a position in Xylem in Q3 2020 and has held it in 11 quarters since.
  • Raymond James Trust's Xylem position peaked at $522K in Q2 2023.
  • 1,016 funds tracked by Wall St. Rank held Xylem as of Q3 2024.

Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.